Opioid addiction is target of new JGH guidelines
As the toll of opioid addiction grows, new JGH guidelines have been approved to reduce the maximum amount of opioid medication that some surgery patients receive when discharged from the hospital.
JGH takes increasingly active role in dental research
Dental research is playing an increasingly significant role in the Lady Davis Institute, especially in an exploration of pain in and around the joint on either side of the jaw bone—second only to back disorders as a source of chronic pain.
Senate bestows 150th Anniversary Medal on Dr. Bernard Lapointe
Dr. Bernard Lapointe, JGH Chief of Palliative Care and an internationally recognized leader in his field, has been honoured with a 150th Anniversary Medal by the Senate of Canada.
Link found between pain reliever
and hypoglycemia
Tramadol, a weak opioid for treating moderate to moderately severe pain, can be linked in some cases to an increased risk of hospitalization for hypoglycemia, concludes a study by a team of epidemiologists in the Lady Davis Institute at the JGH.